Creso Pharma Acquires Australian Psychedelic Medicine Company


Creso Pharma has agreed to fully acquire Australia-based Health House International, which works in the international distribution of medical cannabis products and is licensed to store and trade controlled substances including psilocybin and MDMA. Ganjapreneur reports Creso Pharma has signed a deal to acquire 100% of Australia-based Health House International (HHI), which is focused on 


Read More 

Cannabis Law Report 

This site uses Akismet to reduce spam. Learn how your comment data is processed.